seltenpharma.comContact us
About company
Selten Pharma was founded in 2014 with a focus on developing treatments for rare and life threatening diseases. In Jan 2017, Selten’s PAH assets were acquired by VIVUS, Inc.
Unknown
Unknown
Not verified company
Selten Pharma was founded in 2014 with a focus on developing treatments for rare and life threatening diseases. In Jan 2017, Selten’s PAH assets were acquired by VIVUS, Inc.
